Regeneron and Lilly have applied to the FDA for approval of...

Regeneron and Lilly have applied to the FDA for approval of...
Regeneron and Lilly have applied to the FDA for approval of...

Lilly and Regeneron revealed that the two drugs had proven effective in clinical trials, and that they had submitted an emergency use permit to the US Food and Drug Administration (FDA).FDA), And the US government expects to be able to provide more than a million doses of antibody treatments for Coronavirus COVID-19 Without the comparable cost that President Donald received to treat his illness, according to a senior US health official.

Program contains Operation Warp Speed The government is currently on “a few hundred thousand doses” of monoclonal antibody therapies being developed by pharmaceutical companies Regeneron And Eli Lilly .

That will exceed a million doses by the end of the year, said Paul Mango, a US Department of Health and Human Services official, as Trump received Regeneron treatment. Regeneron Last week, Trump said he was working to get the two drugs approved quickly, and that he may not have recovered from Corona Virus Without the treatments he received.

According to the British “Daily Mail” newspaper, it is a cure Regeneron It is a combination of two antibodies designed to protect against the virus, while Lily’s Lilly’s It is only one antibody.

It is unclear how long the FDA approval process will take to allow the use of drugs in emergency situations, unless companies obtain this permission, doctors cannot give drugs to patients outside of clinical trials, or without the kind permission to use like the one obtained by President Trump..

If the drugs are licensed for use by the US agency, Mango added, the government will allocate treatments to states based on need, similar to the mechanism used with Gilead’s antiviral drug Remdesivir. Gilead In order to treat Corona virus COVID-19.

Occurred Regeneron A deal worth $ 450 million in July to sell enough doses of her antibody treatment. RAIN-COV2 To treat about 300,000 people, as part of an operation Warp Speed , Explaining that she did not sign any additional agreements with Operation Warp Speed, And it has about 50,000 doses of the remedy ready now.

Lilly said it had not signed an agreement with Operation Warp SpeedShe expects to produce about 1 million doses of the drug this year.

These were the details of the news Regeneron and Lilly have applied to the FDA for approval of... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

NEXT Saudi Arabia, China discuss collaboration in urban development during Beijing meeting